✦ LIBER ✦

Desquamative Interstitial Pneumonitis (DIP) occurring during treatment with pegylated interferon and ribavirin

✍ Scribed by Elisa Calabrò; Maurizio Zompatori; Venerino Poletti; Dario Olivieri

Book ID: 113878212
Publisher: Elsevier
Year: 2009
Tongue: English
Weight: 215 KB
Volume: 2
Category: Article
ISSN: 1755-0017
DOI: 10.1016/j.rmedc.2008.10.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nephrotic syndrome during treatment with

Nephrotic syndrome during treatment with pegylated interferon alfa and ribavirin. A case report

✍ Giancarlo Spinzi; Paolo Grillo; Natalia Terreni; Giovanna Mandelli; Alessandra B 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 45 KB

IRREVERSIBLE ALOPECIA UNIVERSALIS DURING

IRREVERSIBLE ALOPECIA UNIVERSALIS DURING TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR CHRONIC HCV INFECTION

✍ B. Omazzi; G. Borroni; A. Bortoli; A. Prada 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Interstitial granuloma annulare after tr

Interstitial granuloma annulare after treatment with pegylated interferon-alfa and ribavirin in a patient with hepatitis C virus infection

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Influence of ITPA polymorphisms on decre

Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir

✍ Fumitaka Suzuki; Yoshiyuki Suzuki; Norio Akuta; Hitomi Sezaki; Miharu Hirakawa; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Polymorphisms of the inosine triphosphatase (ITPA) gene influence anemia during pegylated interferon (PEG-IFN) and ribavirin (RBV) therapy, but their effects during triple therapy with PEG-IFN, RBV, and telaprevir are not known. Triple therapy for 12 weeks, followed by PEG-IFN and RBV for 12 weeks,

Early ribavirin pharmacokinetics, HCV RN

Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin

✍ Harel Dahari; Marianthi Markatou; Marija Zeremski; Ivan Haller; Ruy M. Ribeiro; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 243 KB

1011 Occurrence of infections during com

1011 Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: role of neutropenia and of interferon pegylation

✍ PUOTI, M; ANTONINI, M; BABUDIERI, S; MAIDA, I; FENU, L; MURA, M; SASSU, S; BAIGU 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB